,,iv #aac? ,,congress #a/ ,session ,h4 ,,res4 #acc ,,9 ,,! ,,h\se ,,( ,,repres5tatives ,m>* #ba1 #bjac ,mr4 ,engel 7= himself1 ,mr4 ,"y ( ,alaska1 ,mr4 ,g5e ,gre5 ( ,texas1 ,ms4 ,s*ak[sky1 ,mr4 ,lev91 ,mr4 ,smi? ( ,wa%+ton1 ,mr4 ,honda1 ,mrs4 ,c>olyn ,b4 ,maloney ( ,new ,york1 ,ms4 ,lee ( ,cali=nia1 ,mr4 ,payne1 ,ms4 ,roybal-,all>d1 ,mr4 ,ha/+s ( ,florida1 & ,ms4 ,l(gr57 submitt$ ! foll[+ resolution2 :i* 0 ref]r$ to ! ,committee on ,=eign ,affairs1 & 9 addition to ! ,committee on ,en]gy & ,comm]ce1 = a p]iod to be subsequ5tly det]m9$ by ! ,speak]1 9 ea* case = consid]ation ( su* provisions z fall )9 ! jurisdiction ( ! committee conc]n$ ,,resolution ,comm5d+ ! progress made by anti-tub]culosis programs4 ,:]eas tub]culosis 7,,tb7 is ! second lead+ fatal global infecti\s disease beh9d ,,hiv_/,,aids1 claim+ #c p ea* m9ute & #a1djj1jjj lives ea* ye>2 ,:]eas ! global ,,tb p&emic & ! spread ( drug-resi/ant ,,tb pres5t a p]si/5t public heal? ?reat to ! ,unit$ ,/ates1 & cases ( drug-resi/ant ,,tb 9 ! ,unit$ ,/ates h increas$2 ,:]eas ,,tb treatm5t is long & ardu\s1 rang+ f #f mon?s to #b ye>s1 & requires multiple m$ications1 & ! side effects ( treatm5t = drug-resi/ant ,,tb c include acute pa9 & he>+ loss2 ,:]eas p]iodic ,,tb drug %ortages h occurr$ 9 _m c\ntries1 includ+ ! ,unit$ ,/ates1 because ( insuffici5t production by manufactur]s & supply *a9 problems2 ,:]eas ! fir/ new drug to treat ,,tb 9 ! la/ #dj ye>s 0 approv$ by ! ,,fda 9 ,janu>y #bjac2 ,:]eas diabetic pati5ts are #c times m likely to develop ,,tb comp>$ to ^? )\t diabetes2 ,:]eas ,,tb is ! lead+ kill] ( p ) ,,hiv_/,,aids 9 ! develop+ _w1 m ?an #a1jjj p infect$ ) ,,hiv die e day f tub]culosis1 & !re is also a critical ne$ = new ,,tb drugs t c safely be tak5 concurr5tly ) antiretroviral !rapy = ,,hiv2 ,:]eas heal? c>e work]s are #b to #c times m likely to contract ,,tb ?an ! g5]al population1 yet protection f infection is inadequate 9 _m c\ntries2 ,:]eas ,,tb is an "u-recogniz$ problem 9 *ildr5 & curr5t p$iatric treatm5ts & diagno/ics are inadequate2 ,:]eas ! disease c h deva/at+ long-t]m heal? effects includ+ deafness1 bl9dness1 & p>alysis1 ev5 aft] cure2 ,:]eas ,,tb is ! ?ird lead+ kill] ( adult wom51 & ! /igma associat$ ) ,,tb disproportionately affects wom51 (t5 caus+ delays 9 seek+ c>e & int]f]+ ) treatm5t adh]5ce2 ,:]eas breadw9n]s :o become ill ) ,,tb are (t5 too sick to "w = weeks or mon?s1 :i* c lead to f9ancial cata/rophe = _! families2 ,:]eas ! ,in/itute ( ,m$ic9e 7,,iom7 f\nd t ! resurg5ce ( ,,tb 9 ! ,unit$ ,/ates betwe5 #aihe & #aiib 0 caus$ by cuts 9 ,,tb control fund+ & ! spread ( ,,hiv_/,,aids2 ,:]eas ! numb]s ( ,,tb cases 9 ! ,unit$ ,/ates cont9ue to decl9e2 ,:]eas drug-resi/ant ,,tb t appe>s resi/ant to all m$ication has be5 f\nd 9 ,india & ,s\? ,africa1 & ! ,unit$ ,/ates has _h m ?an #bh cases ( ,ext5sively ,drug-,resi/ant ,,tb 7,,xdr-,,tb7 ov] ! la/ decade1 ) #f cases 9 #bjaa alone2 ,:]eas !re are indications t drugs sold ov] ! c\nt] 9 ph>macies 9 sev]al c\ntries ) poor national drug control sy/ems may be fake or sub-/&>d2 ,:]eas ,african-,am]icans are #h times m likely to h ,,tb ?an ,caucasians1 & significant disp>ities exi/ among o!r m9orities 9 ! ,unit$ ,/ates1 includ+ ,native ,am]icans1 ,asian-,am]icans1 & ,hispanic-,am]icans2 ,:]eas al?\gh drugs1 diagno/ics1 & vacc9es = ,,tb exi/1 _m are antiquat$ & are increas+ly inadequate = controll+ ! global epidemic2 ,:]eas ! ,,tb vacc9e1 ,,bcg1 provides "s protection to *ildr51 b x has little or no efficacy 9 adults2 ,:]eas progress has be5 made 9 vacc9e rese>*1 ) m ?an a doz5 vacc9e c&idates 9 cl9ical trials2 ,:]eas enactm5t ( ! ,tom ,lantos & ,h5ry ,j4 ,hyde ,unit$ ,/ates ,global ,lead]%ip ,aga9/ ,,hiv_/,,aids1 ,tub]culosis1 & ,mal>ia ,reau?orization ,act ( #bjjh & ! ,compreh5sive ,,tb ,elim9ation ,act provid$ a hi/oric ,unit$ ,/ates commitm5t to ! global eradication ( ,,tb1 lead+ to ! successful treatm5t ( #d1ejj1jjj new ,,tb pati5ts & #ij1jjj new multi-drug-resi/ant cases by #bjac1 :ile provid+ additional treatm5t ?r\gh coord9at$ multilat]al ef=ts2 ,:]eas an e/imat$ #bj1jjj1jjj p are alive today z a direct result ( ,,tb programs2 ,:]eas a new1 ,unit$ ,/ates-develop$ diagno/ic te*nology1 call$ ,xp]t1 is revolutioniz+ ! ,,tb response2 ,:]eas ,,tb-relat$ dea?s among p liv+ ) ,,hiv 9 ,africa h decl9$ by #bh p]c5t s9ce #bjjd2 ,:]eas ! ,unit$ ,/ates ,ag5cy = ,int]national ,developm5t 7,,usaid7 provides f9ancial & te*nical assi/ance to ne>ly #cb highly burd5$ ,,tb c\ntries1 supports ! developm5t ( new diagno/ic & treatm5t tools1 & is au?oriz$ to support rese>* to develop new vacc9es to combat ,,tb2 ,:]eas ! ,c5t]s = ,disease ,control & ,prev5tion 7,,cdc71 work+ 9 p>tn]%ip ) ,/ates & t]ritories ( ! ,unit$ ,/ates1 directs ! national ,,tb elim9ation program & ess5tial national ,,tb surveillance1 te*nical assi/ance1 & prev5tion activities & supports ! developm5t ( new diagno/ic1 treatm5t1 & prev5tion tools to combat ,,tb2 ,:]eas ! ,unit$ ,/ates ,presid5t's ,em]g5cy ,plan = ,,aids ,relief 7,,pepf>7 supports programs to integrate ! prev5tion1 diagnosis1 & treatm5t ( ,,tb into ,,hiv s]vices1 z well z programs to integrate ,,hiv prev5tion1 te/+1 c>e1 & treatm5t into ,,tb programs2 ,:]eas ! ,national ,in/itutes ( ,heal?1 ?r\gh its _m in/itutes & c5t]s1 plays ! lead+ role 9 basic & cl9ical rese>* into ! id5tification1 treatm5t1 & prev5tion ( ,,tb2 ,:]eas ! ,global ,fund to ,fight ,,aids1 ,tub]culosis1 & ,mal>ia provides #ij p]c5t ( all int]national f9anc+ = ,,tb programs worldwide & has support$ ! detection & treatm5t ( #i1gjj1jjj cases ( ,,tb2 & ,:]eas ,m>* #bd1 #bjac1 is ,_w ,tub]culosis ,day1 commemorat+ ! date 9 #ahhb :5 ,dr4 ,rob]t ,ko* ann\nc$ 8 discov]y ( ,mycobact]ium tub]culosis1 ! bact]ia t causes tub]culosis3 ,n[1 !re=e1 be x ,t ! ,h\se ( ,repres5tatives-- 7#a7 supports ! goals ( ,_w ,tub]culosis ,day to raise aw>5ess ab\t tub]culosis2 7#b7 comm5ds ! progress made by ,unit$ ,/ates-l$ anti-tub]culosis programs2 & 7#c7 reaffirms its commitm5t to global tub]culosis control made ?r\gh ! ,tom ,lantos & ,h5ry ,j4 ,hyde ,unit$ ,/ates ,global ,lead]%ip ,aga9/ ,,hiv_/,,aids1 ,tub]culosis1 & ,mal>ia ,reau?orization ,act ( #bjjh4